Results from the largest multi-site study to date evaluating a peptide-derived therapeutic vaccine for melanoma show promising evidence that researchers can activate a patient's own immune system to fight advanced melanoma.
Lebrikizumab Demonstrates Promising Results in Atopic Dermatitis
The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques
Highlights from AAD 2023
The Cutaneous Connection: JAK Inhibitor Safety for Treating AD
New Technology Could Allow Us to Rethink Alopecia Scores
Upadacitinib Advances to Phase 3 Clinical Trials in Systemic Lupus Erythematosus
2 Clarke Drive Cranbury, NJ 08512